Interpretation of histiocytic/dendritic cell neoplasms and stromal-derived neoplasms of lymphoid tissues in the 5th edition of WHO classification of haematolymphoid tumors.
10.3760/cma.j.cn112151-20230907-00150
- Author:
W H YIN
1
;
X Q LI
2
Author Information
1. Department of Pathology, Peking University Shenzhen Hospital, Shenzhen 518036, China.
2. Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Lymphoid Tissue/pathology*;
Soft Tissue Neoplasms/pathology*;
Dendritic Cell Sarcoma, Follicular/pathology*;
Dendritic Cells/pathology*;
World Health Organization
- From:
Chinese Journal of Pathology
2024;53(1):12-15
- CountryChina
- Language:Chinese
-
Abstract:
The 5th edition of the World Health Organization classification of hematolymphoid tumors (WHO Blue Book) is soon to be published. Significant revisions have been made in the chapters on histiocytic/dendritic cell neoplasms and stroma-derived neoplasms of lymphoid tissues, leading to the reclassification and renaming of specific diseases. This article provides a concise interpretation and summary of these updates, highlighting the differences from the fourth edition. Pertinent changes from clinical pathological diagnosis to treatment and prognosis are explored, with an emphasis on recent advancements in molecular genetics. Newly introduced disease classifications are discussed, and the section on follicular dendritic cell sarcoma contributed by the author is detailed to assist readers in quickly understanding and assimilating the new classification standards.
